AUSTIN, Texas, Aug. 30 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX) today announced that management will present at the Thomas Weisel Partners Healthcare Conference to be held September 5 - 7, 2007, in Boston.
The investor presentation by Patrick J. Balthrop, president and chief executive officer, and Harriss T. Currie, chief financial officer, will begin at 1:30 p.m. Eastern time on Thursday, September 6, 2007. The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for one year on the website using the 'replay' link.
Luminex Corporation develops, manufactures and markets proprietary biological testing technologies with applications throughout the life sciences industry. The Company's xMAP(R) system is an open-architecture, multi-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is in use in leading research laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP can be obtained on the Internet at http://www.luminexcorp.com.
Contact: Harriss T. Currie
Vice President, Finance and Chief Financial Officer
|SOURCE Luminex Corporation|
Copyright©2007 PR Newswire.
All rights reserved